Negotiated Procedure for Triennial Supply of Exclusive Medicines for DPC of ASP Palermo and SSR of Sicily (4 Lots)

The Region of Sicily is conducting a negotiated procedure without prior public advertisement for a triennial supply of exclusive medicines, divided into four lots. These medicines are required for the Direct Pharmaceutical Assistance (DPC) of the ASP (Azienda Sanitaria Provinciale) of Palermo and for the Regional Health Service (SSR) of Sicily. The tender adheres to the provisions of DPCM 11/7/2018. The overall estimated value is substantial at EUR 135,876,433.50. The four lots specify distinct pharmaceutical products: Lot 1 is for Dulaglutide 0.75 mg (EUR 29,740,284.00), Lot 2 for Dulaglutide 1.5 mg (EUR 92,110,176.00), Lot 3 for Interferon Beta 1a (EUR 4,055,040.00), and Lot 4 for Leuprolide Acetate (EUR 9,970,933.50). The CPV code is 'Various medicinal products'. This procurement is critical for ensuring the continuous availability of essential and specialized medications across healthcare facilities in Sicily. The awardee for Lot 1 was ELI LILLY ITALIA S.P.A. for EUR 18,170,354.16.

This is a supplies contract in the general supplies sector. Located in Italy, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 135.9 million.

Published through ANAC (Italy), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the general supplies sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.